We talk pharmacogenomics with Jean-Claude Marshall of Pfizer: where the focus should be, next generation sequencing and the FDA’s draft guidance for LDTS.
Vanderbilt University survey clinicians on pharmacogenomic attitudes It’s often said that the biggest barrier to integrating genomics into routine healthcare, is healthcare itself. There are doubts over how well equipped clinicians are to manage genomic data, or act on genomic test results. If you’ve been to any of the big conferences this summer, you’ve likely […]
New collaboration between Foundation Medicine and H3 aims to develop precision cancer therapies.
A new UK based project, seeks to improve understanding of blood cancer genomics for improved treatment.